![Theodore Quinlan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Theodore Quinlan
Plus aucun poste en cours
Profil
Theodore Quinlan is Vice President, Controller and Principal Accounting Officer of TranSwitch Corp., which he joined in October 2006.
He was Vice President-Finance and Chief Financial Officer of Molecular Staging, Inc. from 2003 to 2005 and resigned on January 15, 2007.
Mr. Quinlan received a BS degree in Business Administration from State University of New York College at Oswego and an MBA from Syracuse University.
Anciens postes connus de Theodore Quinlan
Sociétés | Poste | Fin |
---|---|---|
TRANSWITCH CORPORATION | Comptroller/Controller/Auditor | 15/01/2007 |
Molecular Staging, Inc.
![]() Molecular Staging, Inc. Medical SpecialtiesHealth Technology Molecular Staging, Inc. (MSI) developed products for the detection & measurement of proteins and nucleic acids. The company's amplification technologies included products & services that identify individual and multiplexed sets of biomarkers & a method of generating DNA from a few cells. MSI enabled transformational products and services across multiple health care markets. The company was founded in 1998 and was located in New Haven, CT. | Directeur Financier/CFO | 15/01/2007 |
Formation de Theodore Quinlan
State University of New York College at Oswego | Undergraduate Degree |
Syracuse University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
TRANSWITCH CORPORATION | Electronic Technology |
Entreprise privées | 1 |
---|---|
Molecular Staging, Inc.
![]() Molecular Staging, Inc. Medical SpecialtiesHealth Technology Molecular Staging, Inc. (MSI) developed products for the detection & measurement of proteins and nucleic acids. The company's amplification technologies included products & services that identify individual and multiplexed sets of biomarkers & a method of generating DNA from a few cells. MSI enabled transformational products and services across multiple health care markets. The company was founded in 1998 and was located in New Haven, CT. | Health Technology |